Natural history of early primary biliary cirrhosis

Lancet

Volumn 348, Issue 9039, 1996, Pages 1399-1402

  Metcalf, Jane V ^c   Mitchison, Harriet C ^b   Palmer, Jeremy M ^a   Jones, David E ^c   Bassendine, Margaret F ^c   James, Oliver F W ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRION ANTIBODY; OXOGLUTARATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; CAUSE OF DEATH; CHOLESTASIS; CLINICAL ARTICLE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER HISTOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0012453837     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)04410-8     Document Type: Article

References (17)

1. 1 Long RG, Scheuer PJ, Sherlock S. Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology 1977; 72: 1104-07.
2. 2 Mitchison HC, Lucey MR, Kelly PJ, Neuberger JM, Williams R, James OFW. Symptom development and prognosis in primary cirrhosis: a study in two centres. Gastroenterology 1990; 99: 778-84.
3. 3 Jeffrey GP, Reed WD, Shilkin KB. Primary biliary cirrhosis: clinicopathological characteristics and outcome. J Gastroenterol Hepatol 1990; 5: 639-45.
4. 4 Mahl RC, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 1994; 20: 707-13.
5. 5 Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histological features in asymptomatic and primary biliary cirrhosis. N Engl J Med 1983; 301: 1-7.
6. 6 Balasubramanian K, Grambasel PM, Wiesner RH, Lindor KD, Dickson ER. Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study. Gastroenterology 1990; 98: 1567-71.
7. 7 Nyberg A, Loof L. Primary biliary cirrhosis: clinical features and outcome with special reference to asymptomatic disease. Scand J Gastroenterol 1989; 24: 57-64.
8. 8 Christensen E, Altman DG, Neuberger J, De Stavola BL, Tygstrup N, Williams R. Updating prognosis in primary biliary cirrhosis using a time dependent Cox regression model. Gastroenterology 1993; 105: 1865-76.
9. 9 Mitchison HC, Bassendine MF, Hendrick A, et al. Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology 1986; 6: 1279-84.
10. 10 Portmann BC, MacSween RNM. Diseases of the intrahepatic bile ducts. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC, eds. Pathology of the liver, 3rd edn. Edinburgh: Churchill-Livingstone, 1994: 477-512.
11. 11 Palmer JM, Bassendine MF, James OFW, Yeaman SJ. Human pyruvate dehydrogenase complex as an autoantigen in primary biliary cirrhosis. Clin Sci 1993; 85: 289-93.
12. 12 Lehmann A, Bassendine MF, James OFW. Is primary biliary cirrhosis a different disease in the elderly? Gerontology 1985; 31: 186-94.
13. 13 Heseltine L, Turner IB, Fussey SP, et al. Primary biliary cirrhosis: quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression. Gastroenterology 1990; 99: 1786-92.
14. 14 Yeaman SJ, Fussey SPM, Danner DJ, James OFW, Mutimer DJ, Bassendine MF. Primary biliary cirrhosis - identification of two major M2 mitochondrial autoantigens. Lancet 1988; i: 1067-70.
15. 15 Fussey SP, Guest JR, James OF, Bassendine MF, Yeaman SJ. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 1988; 85: 8654-58.
16. 16 Berg PA, Klein R. Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance. Dig Dis 1992; 10: 85-101.
17. 17 Mutimer DJ, Fussey SP, Yeaman SJ, Kelly PJ, James OFW, Bassendine MF. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis. Hepatology 1989; 10: 403-07